PARIS – Biocorp, a company specializing in the development and manufacturing of medical devices and smart-drug delivery systems, has received CE marking for its Easylog smart cap for insulin pen injectors. “Our ambition is to develop and market innovative devices boosting compliance, a key factor for the successful treatment of chronic conditions such as diabetes,” said Eric Dessertenne, COO of Biocorp, in a statement. “We are particularly pleased to reach this milestone that confirms our pioneering position in the digitalization of drug delivery devices and will contribute to achieve our growth objectives.” Easylog is a smart sensor that turns all classic pen injectors into connected devices by capturing key treatment information and transferring it to a monitoring mobile app. Market launch is planned for 2018.
You are here: / / Biocorp insulin pen smart cap receives CE mark